Can IVF be done again after failure in Hong Kong, how long to wait, key success factors
After a failed IVF in Hong Kong, you can try again, usually recommended to wait 1-3 menstrual cycles. The success rate of a subsequent attempt depends on factors such as the cause of failure, age, and ovarian reserve. A systematic evaluation including embryo chromosome, endometrial receptivity, and immune factors is needed to adjust the protocol before the next transfer.
Author identity
“Doctor, I have had two failed IVF attempts in Hong Kong. Is there still a chance? Can I try again?”
This is one of the most frequently asked questions in the reproductive medicine outpatient clinic. As a doctor with over ten years of clinical experience in reproductive medicine, I encounter patients with the same confusion every day. Today, we will systematically discuss this issue — after a failed IVF in Hong Kong, can you try again, and how to improve the success rate of the next attempt.
Direct Answer: You can try again after a failed IVF in Hong Kong
From a clinical practice and evidence-based medicine perspective, it is entirely possible to undergo another IVF treatment after a failed attempt in Hong Kong. The key lies in the interval time and systematic analysis of the cause of failure.
- Interval time: Generally, it is recommended to rest for 1 to 3 menstrual cycles. The specific duration should be individualized based on physical recovery, ovarian function status, and complications from the previous treatment (such as OHSS risk). For patients in good physical condition, they may proceed directly to the preparation process in the next menstrual cycle after a doctor's assessment.
- Prerequisite for another attempt: A systematic evaluation of the previous failure must be conducted to identify the cause, rather than simply repeating the original protocol.
- Probability of success again: Depends on whether the cause of failure is correctable, age, ovarian reserve function, uterine environment, and other factors. For younger individuals with a clear and intervenable cause of failure, the cumulative pregnancy rate for subsequent attempts can reach 40% to 60% (based on clinical data from similar populations).
Details Most Easily Overlooked
In clinical practice, the following details are often overlooked by patients and even some clinicians, but they may be the real reasons for recurrent failure:
- Embryonic Chromosomal Aneuploidy: In older patients (≥38 years) or those with diminished ovarian reserve, the rate of embryonic aneuploidy increases significantly. Even blastocysts with high morphological scores may have chromosomal abnormalities. PGT-A screening can significantly reduce implantation failure or miscarriage caused by aneuploidy.
- Endometrial Receptivity Abnormality: About 15% to 20% of patients with recurrent implantation failure have a displaced window of endometrial receptivity. ERA (Endometrial Receptivity Array) testing can precisely locate the implantation window.
- Chronic Endometritis: Asymptomatic chronic endometritis (CD138+ cell infiltration) can affect endometrial receptivity. Hysteroscopy + endometrial biopsy + immunohistochemistry are the gold standard for diagnosis.
- Immune Factors: Including abnormal NK cell activity, lack of blocking antibodies, thyroid autoantibodies, antiphospholipid antibodies, etc. However, immune intervention requires strict indications to avoid overtreatment.
- Vitamin D Levels: Vitamin D deficiency is associated with an increased risk of IVF failure. Routine testing of 25(OH)D and supplementation to an appropriate level (≥30 ng/mL) is recommended.
These details are easily missed in routine evaluations, but for patients with recurrent failure, each one is worth systematic investigation.
Analysis of Common Causes of IVF Failure in Hong Kong
The causes of IVF failure are multidimensional, involving embryonic, uterine, immune, endocrine, genetic, and environmental factors. The following are the most common categories:
- Embryonic Factors (highest proportion, about 50% to 60%): Including chromosomal aneuploidy, mosaicism, genetic abnormalities, embryonic developmental arrest, low blastocyst formation rate, etc. PGT-A and embryo morphological assessment are the main analysis tools.
- Endometrial Factors (about 20% to 30%): Including insufficient endometrial thickness (<7 mm), abnormal endometrial morphology, displaced window of endometrial receptivity, chronic endometritis, intrauterine adhesions, endometrial polyps, fibroids (submucosal type), etc. Hysteroscopy is the gold standard for diagnosing uterine cavity pathology.
- Immune and Coagulation Factors (about 10% to 15%): Including antiphospholipid syndrome, abnormal NK cells, Treg/Th1/Th2 imbalance, coagulation abnormalities (such as increased platelet aggregation rate, elevated D-dimer, etc.).
- Endocrine and Metabolic Factors: Including thyroid dysfunction (especially subclinical hypothyroidism), hyperprolactinemia, vitamin D deficiency, insulin resistance, abnormal BMI (too high or too low), etc.
- Male Factors: High sperm DNA fragmentation index (DFI), sperm chromosomal aneuploidy, Y chromosome microdeletion, etc., may affect embryonic developmental potential.
In reproductive medicine centers in Hong Kong, for patients with recurrent failure, a multidisciplinary comprehensive evaluation is usually recommended, including collaboration among reproductive medicine, genetics, immunology, endocrinology, and psychology.
Differences and Strategies by Age Group
Age is one of the most important variables affecting the success rate of subsequent attempts after IVF failure. The following is an objective analysis based on real-world data:
| Age Range | Ovarian Reserve Characteristics | Key Strategy for Subsequent Attempt After Failure | Reference Cumulative Live Birth Rate (within 3 cycles) |
|---|---|---|---|
| ≤ 34 years | Normal reserve, AMH ≥ 2.0 ng/mL | Focus on investigating embryonic aneuploidy (PGT-A), uterine cavity environment, immune factors; generally good prognosis | 50% to 65% |
| 35 to 37 years | Mildly diminished reserve, AMH 1.0 to 2.0 ng/mL | Recommend PGT-A screening + ovarian function optimization (Coenzyme Q10, individualized DHEA use) | 40% to 55% |
| 38 to 40 years | Moderately diminished reserve, AMH 0.5 to 1.0 ng/mL | Strongly recommend PGT-A + ERA + hysteroscopy; consider DuoStim or PPOS protocol to increase oocyte yield | 25% to 40% |
| 41 to 42 years | Significantly diminished reserve, AMH 0.3 to 0.5 ng/mL | Focus on oocyte quantity and embryo screening; consider oocyte donation as an alternative | 10% to 20% |
| ≥ 43 years | Reserve depletion, AMH < 0.3 ng/mL | Very low success rate with own eggs; strongly recommend discussing alternative paths such as oocyte donation or adoption | <5% |
Note: Cumulative live birth rate data is based on recent real-world data from major reproductive centers in Hong Kong and internationally. Individual variations exist. This is for reference only and does not constitute a guarantee of success for any individual.
Case Scenario Analysis: A Systematic Review After a Typical Failure
Basic Information: 38 years old, AMH 1.2 ng/mL, FSH 9.8 mIU/mL, BMI 22.5, previously healthy, no pregnancy history. First IVF at a reproductive center in Hong Kong using an antagonist protocol, 8 oocytes retrieved, 6 MII oocytes, 2 blastocysts formed (4BB, 4BC), 1 fresh 4BB blastocyst transferred, no implantation.
Systematic Analysis After Failure:
- Embryo chromosome (PGT-A): The remaining 1 blastocyst tested positive for trisomy 16 (aneuploidy)
- Hysteroscopy: Smooth endometrium, no polyps or adhesions, CD138 (-)
- ERA: Normal endometrial receptivity window (Day 6)
- Immune screening: Antiphospholipid antibodies (-), NK cell activity normal, Vitamin D 17 ng/mL (insufficient)
Analysis Conclusion: The primary cause of the previous failure was embryonic aneuploidy (sporadic), along with vitamin D insufficiency.
Adjusted Protocol: Supplement vitamin D to ≥30 ng/mL; next stimulation using PPOS protocol + PGT-A screening, select euploid embryo for frozen embryo transfer.
Outcome: Second stimulation yielded 10 oocytes, 3 blastocysts formed, PGT-A indicated 2 euploid, clinical pregnancy achieved after single frozen embryo transfer.
This case demonstrates the value of systematic failure cause analysis — identifying the root cause and adjusting the protocol accordingly can significantly improve success rates.
Doctor's Perspective: Failure is Not an End, But an Opportunity to Recalibrate
As a reproductive specialist, I often tell my patients: “A failed IVF does not mean you have no chance; it means we haven't yet found the most suitable protocol for you.” From a clinical perspective, the right attitude towards failure is:
- View failure as a diagnostic tool: Each failed attempt provides important information about your body's response, helping the doctor optimize the next strategy.
- Avoid emotional decisions: Do not immediately switch hospitals or doctors after a failure. Instead, first complete a systematic evaluation at the current center. Reproductive centers in Hong Kong generally have comprehensive failure analysis systems, including PGT-A, ERA, hysteroscopy, and immune screening.
- Focus on “cumulative success rate” rather than “single-cycle success rate”: One failed transfer does not mean the entire cycle failed. For patients with frozen embryos, the cumulative pregnancy rate is usually significantly higher than the single transfer success rate.
- Individualization is key: No two patients are exactly alike. Age, ovarian reserve, etiology, lifestyle, and other factors collectively determine the best strategy. So-called “standard protocols” often need adjustment in patients with recurrent failure.
Common Pitfalls: These Mistakes Can Reduce the Chance of Success in Subsequent Attempts
Based on clinical observations, the following practices are the most common misconceptions among patients with recurrent failure:
- Mistake 1: “More attempts will eventually lead to success” — Blindly repeating the same protocol without cause analysis wastes time and financial resources and may cause unnecessary ovarian stimulation from repeated cycles.
- Mistake 2: Blindly switching hospitals or doctors — Changing to another hospital without completing a failure cause analysis may lead to repeating the same mistakes at the new center. It is recommended to first complete a systematic evaluation at the original center before deciding whether to switch.
- Mistake 3: Overemphasizing endometrial thickness while ignoring endometrial receptivity — Endometrial thickness is only a “quantitative” indicator, while endometrial receptivity (window, microbiome, immune status, etc.) is a “qualitative” indicator. Normal thickness but abnormal receptivity can still lead to failure.
- Mistake 4: Self-administering large amounts of supplements — Coenzyme Q10, DHEA, growth hormone, etc., are not suitable for everyone. Misuse can cause side effects or disrupt endocrine status. All supplements should be used under a doctor's guidance.
- Mistake 5: Ignoring psychological and lifestyle factors — Chronic anxiety, sleep deprivation, and high stress can affect endocrine and immune balance. Psychological counseling and lifestyle adjustments are important components of assisted reproduction.
Avoiding these pitfalls can help you take fewer detours and improve efficiency in your next attempt.
Frequently Asked Questions Summary
| Question | Answer |
|---|---|
| How long should I rest after a failed IVF before trying again? | Generally, it is recommended to rest for 1 to 3 menstrual cycles. If a fresh embryo transfer failed, preparation can usually begin after the next menstrual period; if a frozen embryo transfer failed, 1 to 2 months of rest is recommended. The specific duration depends on physical recovery and doctor's assessment. |
| What tests are needed after a failed IVF? | A systematic evaluation is recommended, including: embryo chromosome screening (PGT-A), hysteroscopy, endometrial receptivity (ERA), immune factors (antiphospholipid antibodies, NK cells, thyroid antibodies, etc.), endocrine (TSH, vitamin D, insulin resistance, etc.), male sperm DNA fragmentation index (DFI), etc. |
| Can I use previously frozen embryos after a failed IVF? | If you have frozen embryos with good quality (e.g., blastocyst grade ≥ 3BB), a failure cause analysis should be conducted first. If the analysis shows the problem is not with the embryo itself (e.g., uterine cavity or immune factors), the frozen embryos can be used, but the identified issues must be addressed first. |
| Is there still a chance for older women (≥40 years) after a failed IVF? | There is a chance, but expectations need to be managed. For women aged 40 to 42, selecting euploid embryos for transfer via PGT-A screening yields a cumulative live birth rate of about 10% to 20%. For those over 43, the success rate with own eggs is very low, and alternative options like oocyte donation should be discussed. |
| Should I change hospitals after multiple failed IVF attempts in Hong Kong? | It is not recommended to change hospitals without completing a cause analysis. Reproductive centers in Hong Kong generally have advanced diagnostic capabilities. It is advisable to first complete a multidisciplinary evaluation at the current center. If the evaluation suggests that the center's technology or conditions cannot address your issues, then consider transferring to a center with relevant technical advantages. |
⚠️ Risk Reminder
Assisted reproductive technology (including IVF in Hong Kong) is a complex medical procedure. Attempting again after failure requires a comprehensive assessment of medical indications, physical condition, financial costs, and psychological capacity. The information provided in this article is for medical knowledge popularization only and cannot replace individualized clinical diagnosis and treatment. Special caution is needed in the following situations:
- If there are uncontrolled thyroid diseases, hypertension, diabetes, or other internal medical comorbidities, these conditions must be stabilized before considering another attempt.
- For patients with recurrent failure (≥3 times) of unknown cause, it is recommended to decide on the next steps after a multidisciplinary team (MDT) consultation.
- Older patients (≥43 years) with nearly depleted ovarian reserve should fully understand the very low success rate with own eggs and rationally consider other fertility paths.
- Any subsequent attempt should be conducted at a legally qualified and experienced reproductive medicine center, under the full management of a professional reproductive specialist.
Every treatment decision should be based on sufficient medical information and rational risk assessment, working with your reproductive specialist to develop the most suitable individualized plan for you.
0 comments